Callan Family Office, LLC Astrazeneca PLC Transaction History
Callan Family Office, LLC
- $1.33 Trillion
- Q1 2025
A detailed history of Callan Family Office, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Callan Family Office, LLC holds 19,249 shares of AZN stock, worth $1.34 Million. This represents 0.11% of its overall portfolio holdings.
Number of Shares
19,249
Previous 22,970
16.2%
Holding current value
$1.34 Million
Previous $1.5 Billion
5.99%
% of portfolio
0.11%
Previous 0.1%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,427Shares Held
504MCall Options Held
10MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$3.98 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA40.7MShares$2.83 Billion2.53% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.48 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.22 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.3MShares$2.18 Billion0.47% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $216B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...